| Abstract P223: Estimated Health Benefits, Costs, and Cost-Effectiveness of Eliminating Industrial Trans-Fatty Acids in Nigeria M Marklund, LN Aminde, MN Wanjau, BM Ale, AE Ojo, CE Okoro, ... Circulation 147 (Suppl_1), AP223-AP223, 2023 | | 2023 |
| Assessing the Health and Economic Impact and Cost Effectiveness of Interventions for the Prevention and Control of Overweight and Obesity in Kenya: A Stakeholder Engaged … MN Wanjau 2023 World Congress on Health Economics, 2023 | | 2023 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 V Stein Emil, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... Elsevier, 2024 | | 2024 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 6 | 2024 |
| Does active transport displace other physical activity? A systematic review of the evidence MN Wanjau, Y Dalugoda, M Oberai, H Möller, C Standen, F Haigh, A Milat, ... Journal of Transport & Health 31, 101631, 2023 | 5 | 2023 |
| Estimated health benefits, costs and cost-effectiveness of eliminating dietary industrial trans fatty acids in Kenya: cost-effectiveness analysis M Marklund, LN Aminde, MN Wanjau, L Huang, C Awuor, L Steele, ... BMJ Global Health 8 (10), e012692, 2023 | 1 | 2023 |
| Estimated health benefits, costs and cost-effectiveness of eliminating industrial trans-fatty acids in Nigeria: cost-effectiveness analysis M Marklund, LN Aminde, MN Wanjau, BM Ale, AE Ojo, CE Okoro, ... BMJ Global Health 9 (4), e014294, 2024 | | 2024 |
| Estimated impact of achieving the Australian national sodium reduction targets on blood pressure, chronic kidney disease burden and healthcare costs: a modelling study LN Aminde, MN Wanjau, LJ Cobiac, JL Veerman Nutrients 15 (2), 318, 2023 | 4 | 2023 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 7 | 2024 |
| Health promotion at the workplace setting: a protocol for a systematic review of effectiveness and sustainability of current practice in low-income and middle-income countries MN Wanjau, B Zapata-Diomedi, L Veerman BMJ open 9 (5), e027050, 2019 | 2 | 2019 |
| Physical activity and depression and anxiety disorders in Australia: a lifetable analysis MN Wanjau, H Möller, F Haigh, A Milat, R Hayek, P Lucas, JL Veerman AJPM focus 2 (2), 100030, 2023 | 3 | 2023 |
| Physical activity and depression and anxiety disorders: a systematic review of reviews and assessment of causality MN Wanjau, H Möller, F Haigh, A Milat, R Hayek, P Lucas, JL Veerman AJPM focus 2 (2), 100074, 2023 | 15 | 2023 |
| Potential health and economic impact of achieving Kenya’s overweight and obesity reduction target: a modelling study MN Wanjau, LN Aminde, JL Veerman BMJ Public Health 2 (1), 2024 | | 2024 |
| Projected impact on blood pressure, chronic kidney disease burden and healthcare costs of achieving the Australian sodium reduction targets: a modelling study LN Aminde, M Wanjau, LJ Cobiac, JL Veerman medRxiv, 2022.03. 18.22272639, 2022 | 2 | 2022 |
| Stakeholder perceptions of current practices and challenges in priority setting for non-communicable disease control in Kenya: a qualitative study MN Wanjau, LW Kivuti-Bitok, LN Aminde, L Veerman BMJ open 11 (4), e043641, 2021 | 10 | 2021 |
| Stakeholder-engaged research: strategies for the prevention and control of overweight and obesity in Kenya MN Wanjau, LW Kivuti-Bitok, LN Aminde, JL Veerman BMC Public Health 21, 1-11, 2021 | 7 | 2021 |
| Supplementary File: The potential health and economic impact of achieving Kenya’s overweight and obesity reduction target: a modelling study MN Wanjau | | |
| The avoidable disease burden associated with overweight and obesity in Kenya: A modelling study MN Wanjau, LN Aminde, JL Veerman Eclinicalmedicine 50, 2022 | 9 | 2022 |
| The health and economic impact and cost effectiveness of interventions for the prevention and control of overweight and obesity in Kenya: a stakeholder engaged modelling study MN Wanjau, LW Kivuti-Bitok, LN Aminde, JL Veerman Cost Effectiveness and Resource Allocation 21 (1), 69, 2023 | 5 | 2023 |
| The potential impact of achieving Kenya’s obesity reduction target on health outcomes, healthcare costs, and productivity: a modelling study M Wanjau, L Aminde, L Veerman Population Medicine 5 (Supplement), 2023 | | 2023 |
